Objective-Fibrinogen has a role in inflammatory processes and participates in atherosclerotic plaque formation. Despite intensive investigation, there is no clear evidence for a role of variations in the genes coding for the fibrinogen-␣, fibrinogen-␤, and fibrinogen-␥ polypeptide chains in myocardial infarction. We examined the association of haplotypes in the 50-kb fibrinogen gene region with myocardial infarction in 2 large case-control samples. Methods and Results-Study sample 1 consisted of 3657 patients with myocardial infarction and 1211 control individuals and sample 2 comprised 1392 patients and 1392 controls. Haplotypes were inferred from genotype analyses of tagging single nucleotide polymorphisms dispersed among the fibrinogen genes. The frequencies of these haplotypes were not significantly different between the case and control groups in either sample (PՆ0.07). In addition, haplotypes specific for individual fibrinogen genes were analyzed. No substantial differences in the frequencies of these haplotypes were observed between the groups (PՆ0.13). Finally, haplotypes composed of SNPs that exhibited relatively low pairwise allelic associations among each other were examined. Positive associations between plasma fibrinogen concentrations and the risk of coronary heart disease and myocardial infarction (MI) have been reported from prospective epidemiological studies. [3] [4] [5] [6] However, it is unclear whether the elevations in fibrinogen levels are a causal factor in the development of atherosclerosis or an epiphenomenon of the atherogenic process.
F ibrinogen participates in atherosclerotic plaque formation by modulation of endothelial function and promotion of smooth muscle cell proliferation and migration. 1, 2 It is an important component of the coagulation cascade and a major determinant of blood viscosity and platelet aggregation. 1, 2 Positive associations between plasma fibrinogen concentrations and the risk of coronary heart disease and myocardial infarction (MI) have been reported from prospective epidemiological studies. [3] [4] [5] [6] However, it is unclear whether the elevations in fibrinogen levels are a causal factor in the development of atherosclerosis or an epiphenomenon of the atherogenic process.
High molecular weight (340 kDa) fibrinogen is a glycoprotein containing 2 copies of each of 3 polypeptide chains (A␣, B␤, and ␥) encoded by 3 distinct genes (FGA, FGB, and FGG) that are transcribed separately from each other. 7, 8 The genes are arranged in the order FGG-FGA-FGB within a 50-kb region on the long arm of chromosome 4, with the transcriptional direction of FGG and FGA opposite to that of FGB. 8 Single nucleotide polymorphisms (SNPs) in the FGG-FGA-FGB region have been examined for associations with coronary artery disease and MI, including rs1800792 (Ϫ647A/G) in FGG, rs6050 (Thr312Ala) in FGA, and rs1800790 (Ϫ455G/A) in FGB. In some studies, relationships between SNPs and MI were observed, 9 -14 whereas lack of association was reported from other investigations and metaanalyses. Recent evidence indicated that not individual SNPs but rather SNP-related haplotypes in the fibrinogen gene region were connected with the risk of MI. 33 We addressed the association of SNP-related haplotypes across the FGG-FGA-FGB region with MI in 2 large casecontrol samples. The SNPs used in this analysis represented the majority of genetic variation within the genes and some of them have been linked with gene expression, protein function, and plasma fibrinogen level. 9,19,22,33,38 -52 
Methods
Two case-control samples, sample 1 and sample 2, were examined at Deutsches Herzzentrum München or 1. Medizinische Klinik rechts der Isar der Technischen Universität München. Haplotype-tagging SNPs of the fibrinogen genes were inferred from HapMap data: the rs2066864, rs1049636, and rs1800792 SNPs in FGG, the rs6050 and rs 2070011 SNPs in FGA, and the rs1800790 and rs1800788 SNPs in FGB (HapMap data release 21a/phase II Jan07, on National Center for Biotechnology Information B35 assembly, SNP database build 125; http://www.hapmap.org and http://www.ncbi.nlm.nih.gov/projects/SNP). In addition, the rs1800787, rs1800791, and rs4220 SNPs in FGB were included in the analysis because allele-associated functional differences of these SNPs have been reported. 9, 42, 46, 51 Figure 1 indicates the positions of the SNPs in the fibrinogen gene region selected for examination in this study. Table 1 provides information about the relative positions of the SNPs, major and minor SNP alleles, and alternative designations of the SNPs used in prior publications. TaqMan allelic discrimination assays were designed and used for SNP genotyping.
The statistical analysis consisted of comparing separately allele and haplotype frequencies between the control group and the MI group in sample 1 and sample 2. Discrete variables were compared with the use of the 2 test. Continuous variables are expressed as meanϮSD and were compared by means of the unpaired 2-sided t test. Hardy-Weinberg equilibrium was assessed with the use of the 2 test. Pairwise measures of linkage disequilibrium (DЈ and r 2 ) between the SNPs were calculated from primary genotype data with the software package Haploview. 53 Haplotypes were reconstructed using the software package PHASE. 54 For more detailed Methods, please see the supplemental materials (available online at http://atvb.ahajournals.org).
Results
Main baseline characteristics of the control and MI groups in samples 1 and 2 are presented in Table 2 . Mean age of the patients was higher than that of the control group, the proportion of women was lower in the patient group than in the control group, and history of arterial hypertension and hypercholesterolemia, present cigarrette smoking, and diabetes mellitus were more prevalent in the patient group than in the control group (PϽ0.0001 for all comparisons; Table 2 ). The frequencies of the major alleles of SNPs in the fibrinogen gene region were not significantly different between the control and MI groups in samples 1 and 2 (Table 3) . Genotype distributions in the study groups were consistent with those expected for samples in Hardy-Weinberg equilibrium (PՆ0.17).
Associations among the alleles of the SNPs were calculated from genotype data. Pairwise measures of allelic association, expressed as linkage disequilibrium coefficients DЈ and r 2 , are shown in Figure 2 . Overall high DЈ values indicated low historical recombination within the fibrinogen gene region. Thus, haplotype phase estimation appeared to be reliable across the entire region. Relatively low r 2 values among most of the SNP pairs referred to a disparate evolutionary history of these markers and gave the reasons to perform haplotype analyses. SNP-related haplotypes were established and their frequencies determined in the control and MI groups of samples 1 and 2. Risk estimates showed that the 10-marker haplotypes with frequencies Ͼ1% in the groups of each sample (Hap1 to Hap12) were not associated
rs2070011 rs6050 rs1800788 rs1800790 rs1800791 rs1800787 rs4220 10 kb Figure 1 . Positions of SNPs in the fibrinogen gene region genotyped in the study samples. See Table 1 
RFLP indicates restriction fragment length polymorphism. *Alleles are depicted from the same DNA strand, the coding strand of FGG and FGA, and the noncoding strand of FGB.
with MI (Table 4) . Together, these 12 10-marker haplotypes represented the fibrinogen gene region of approximately 95% of the haploid genomes in the study population. Gene-specific haplotypes were established on the basis of the 12 most frequent 10-marker haplotypes. The proportions of haplotypes related to FGG (rs1800792-rs1049636-rs2066864), FGA (rs2070011-rs6050), and FGB (rs4220-rs1800787-rs1800788-rs1800790-rs1800791) were not significantly different between the control and MI groups in both study samples (supplemental Table I , available online at http://atvb.ahajournals.org).
Finally, intergenic 2-and 3-marker haplotypes of SNPs exhibiting relatively low allelic associations among each other ( Figure 2) were inferred from the 12 most frequent 10-marker haplotypes. Proportions of such haplotypes were not significantly different between the groups, as exemplified by rs1049636-rs2070011 (FGG-FGA) and rs1049636-rs2070011-rs1800790 (FGG-FGA-FGB) (supplemental Table II ).
Discussion
The present results strongly suggest that genetic variations in the fibrinogen gene region are not associated with myocardial infarction. This conclusion was reached on evaluation of alleles and haplotypes in 2 case-control samples which included large numbers of participants.
Systematic examinations, including electrocardiography and left ventricular and coronary angiography, enabled us to safely define case and control status of the study participants. The allele frequencies in the control groups were not significantly different from those observed in other control groups that consisted predominantly (Ͼ92%) or completely of white individuals 9 The sample size provided the analysis with 99% power to detect a 20% increase in the risk of MI among the carriers of the Hap1 haplotype and 72% power to detect a 20% increase in the risk of MI among the carriers of the Hap12 haplotype (2-sided ␣-error 0.05).
In prior studies of fibrinogen genes, SNPs were usually examined one by one, and the results suggested a lack of association with coronary artery disease and MI in most Variables are presented as n (%) of control individuals and MI patients. *FGG, FGA, FGB: genes for fibrinogen-␥, fibrinogen-␣, and fibrinogen-␤, respectively. †Alleles are depicted from the same DNA strand, the coding strand of FGG and FGA, and the noncoding strand of FGB.
instances. Individual SNPs are considered to make at most a small contribution to disease risk, and their potential effects may escape detection when examined separately. 57 Therefore, combined analysis of a series of SNPs, together capturing a major portion of the total genetic variation of the chromosomal region in question, may be more suitable than separate calculations to identify an existing relationship with disease. Mannila et al were the first to undertake such an extensive analysis in the fibrinogen gene region, when they studied the association of haplotypes with MI in a sample of 377 patients and 387 healthy individuals from Sweden. 33 In their analysis, 8 of the SNPs were used that were also examined in the present study, not included were the rs4220 and rs1800787 SNPs. 33 *The order of the alleles in the haplotypes is in accordance with the relative chromosomal positions of the SNPs (from left to right): rs1800792, rs1049636, rs2066864, rs2070011, rs6050, rs4220, rs1800787, rs1800788, rs1800790, rs1800791. Haplotype bases are depicted from the same DNA strand, the coding strand of FGG and FGA, and the noncoding strand of FGB.
†Haplotype frequencies (%) in the control and MI groups.
Mannila et al observed associations of 3 different haplotypes, named FGG-FGA-FGB*1b, 4b, and 5b in their report, with MI. 33 In terms of allelic composition, these haplotypes were entirely equivalent to the 10-marker haplotypes Hap1, Hap3, and Hap5 in the present samples, respectively, because inclusion of the rs4220 and rs1800787 SNPs did not result in altered haplotype diversity. Among the haplotypes that were also addressed here, Mannila et al found higher risks of MI linked to the TG (rs1049636-rs2070011) and TGC (rs1049636-rs2070011-rs1800790) haplotypes and lower risks connected with the ACC (rs1800792-rs1049636-rs2066864), AA (rs2070011-rs6050), CA (rs1049636-rs2070011) and CAC (rs1049636-rs2070011-rs1800790) haplotypes. 33 Obviously, the association data reported by Mannila et al 33 are different from the results of the present study in which no evidence for a relationship of fibrinogen gene haplotypes with MI was obtained. Differences in particular characteristics between the study samples may have accounted for the opposite results. Two case-control samples were examined in the present study each of which was much larger than the sample investigated by Mannila et al. 33 Mean ages of cases and controls were higher in the present investigation than in the prior study. 33 All participants of the present study underwent coronary angiography, whereas in the study conducted by Mannila et al, coronary angiography was incomplete in the patient group and not performed in the control group. 33 Similar to the present results, Uitte de Willige et al 52 reported no association of FGG haplotypes with MI in a sample of 556 patients and 644 control individuals.
The results of our study may not be interpreted as a negation of the potential functional significance of the fibrinogen genes and fibrinogen in atherosclerotic diseases. Lack of measurable associations in these relatively large and welldefined case-control samples may indicate the possibility that SNPs and SNP-related haplotypes in the fibrinogen genes have at best a modest impact on the process resulting in MI. Therefore, the present findings imply that screening of fibrinogen genes is not useful for the assessment of the risk of MI. Other genetic factors 58 in addition to lifestyle and environmental influences may more strongly affect disease development and clinical manifestations.
